ReviewFrontiers in bioengineering and biotechnology2025
Mitochondria and pluripotency: from established models to emerging roles in adult stem cells.
Review in Frontiers in bioengineering and biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed.
- Article
- Review
- Genomic stability of human pluripotent stem cells: advances in research and screening criteria.Stem cells translational medicine · 2026Review
- Mitochondrial Network Dynamics in Aging: Cellular Mechanisms, Intercellular Communication, and Their Impact on Tissue Adaptability.International journal of molecular sciences · 2026Review
- The puzzling duality of mesenchymal stem cells and adipocytes in bone marrow and ageing.npj aging · 2026Review
- A biomimetic and xeno-free platform for corneal engineering: synergy between PRGF technology and human dental pulp stem cells.Frontiers in bioengineering and biotechnology · 2026Article
- Nanoscale biointerfaces in inter-organelle communication: membrane contact sites, organelle trafficking, and cell fate control.Frontiers in cell and developmental biology · 2026Review
- Editorial: Metabolic regulation of stem cell fate.Frontiers in cell and developmental biology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pluripotency, once considered an exclusive attribute of early embryonic cells, is increasingly recognized in certain adult tissue-derived stem cell populations, challenging traditional developmental paradigms. Recent findings highlight mitochondria as key regulators of cellular identity, integrating metabolic status, redox signaling, and epigenetic cues to influence stemness and differentiation. This review synthesizes current knowledge on mitochondrial features (from morphology, dynamics, to bioenergetics and correlation to cellular epigenetic status) in pluripotent stem cells (ESCs and iPSCs) as well as in multipotent adult tissue stem cells (ASC) emphasizing transitions between glycolytic and oxidative metabolism during reprogramming and lineage specification. Particular attention is given to existing evidence on adult pluripotent-like stem cells, including VSELs, MAPCs, MUSE cells, MIAMI, and DFATs, which remain incompletely characterized but demonstrate promising regenerative capacities. While direct data on mitochondrial behavior in these cells are sparse, parallels with multipotent adult stem cells as well as with ESC and IPSCs suggest a model wherein stress-induced bioenergetic shifts, ROS signaling, and mitochondrial remodeling act as modulators of latent pluripotency. Understanding these mechanisms could offer insights on adult pluripotent stem cell role in orchestrating regeneration during major trauma or environmental stress as well as on their distinctive responsiveness compared to ASC. Such an approach could inform future strategies in regenerative medicine, offering novel insights into how adult cells might resume developmental plasticity through mitochondrial balance, intercellular transfer and networking.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.